I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Insidersinvested$26.5mI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamMino-Lokis our leadassetThere are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"We expect tofinish theMino-Loktrial this yearI won't diluteshareholdersNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialWe had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013We willhaveexclusivityI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK'spotentialmarket is>$300mAnymentionof Mino-WrapWe haveenough cashto go wellinto 2023An actualiMSCupdateI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Insidersinvested$26.5mI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamMino-Lokis our leadassetThere are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"We expect tofinish theMino-Loktrial this yearI won't diluteshareholdersNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialWe had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013We willhaveexclusivityI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK'spotentialmarket is>$300mAnymentionof Mino-WrapWe haveenough cashto go wellinto 2023An actualiMSCupdate

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  2. Insiders invested $26.5m
  3. I'm a shareholder myself
  4. Only biotech with 2 Myron's on the leadership team
  5. Mino-Lok is our lead asset
  6. There are no FDA approved drugs to treat hemorrhoids
  7. We intend to submit a BLA in 2H 2022
  8. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  9. We expect to finish the Mino-Lok trial this year
  10. I won't dilute shareholders
  11. Not many companies this size with 2 late stage assets
  12. We will open up international sites for Mino-Lok trial
  13. We had a phase 2b trial with 100% efficacy
  14. Hemorrhoids is a $2B market
  15. I/ONTAK was the best deal I ever made
  16. Mino-Lok potential market >$1B
  17. Myron Holubiak and I founded a private company in 2013
  18. We will have exclusivity
  19. I/ONTAK is our lead asset
  20. Our Halo-Lido trial will have final patient by end of 2022
  21. I/ONTAK's potential market is >$300m
  22. Any mention of Mino-Wrap
  23. We have enough cash to go well into 2023
  24. An actual iMSC update